Expression of Galectin-7 Is Induced in Breast Cancer Cells by Mutant p53
Carole G. Campion(Institut National de la Recherche Scientifique), Yves St‐Pierre(Institut National de la Recherche Scientifique)
Cited by 46
Related Papers
PKC isoforms interact with and phosphorylate DNMT1
|BMC Biology|2011|58
Cytosolic galectin-7 impairs p53 functions and induces chemoresistance in breast cancer cells
|BMC Cancer|2014|34
A Mutation in the Carbohydrate Recognition Domain Drives a Phenotypic Switch in the Role of Galectin-7 in Prostate Cancer
|PLoS ONE|2015|28
5‐Aza‐2′‐deoxycytidine and interleukin‐1 cooperate to regulate matrix metalloproteinase‐3 gene expression
|International Journal of Cancer|2010|7
Development of Galectin-7-Specific Nanobodies: Implications for Immunotherapy and Molecular Imaging in Cancer
|Journal of Medicinal Chemistry|2025|4